Molecular pathology of allergic disease. II: Upper airway disease.
Allergic upper airway diseases such as allergic rhinitis and chronic sinusitis are an increasing problem. Although the pathogenesis remains elusive, an individual's genetic predisposition as well as exposure to the allergen are currently considered factors in their development. Clinical symptoms of sneezing, rhinorrhea, and congestion are primarily a consequence of granulocyte release of chemical mediators such as histamine, prostanoids, and leukotrienes as well as the infiltration of inflammatory cells. Observations subsequent to allergen provocation are comparable to natural exposure and as such much of our understanding of allergic responses is derived from this model. A prominence of CD4(+) T cells and eosinophils, synthesis and release of T(H)2 cytokines, and the coordinate expression of chemokines and adhesion molecules are all characteristic of the allergic response observed in rhinitis and sinusitis. Corticosteroids and immunotherapy target these inflammatory processes and have been observed to successfully reduce and shift the predominantly T(H)2 environment toward T(H)1 cytokine expression. As our understanding of the pathophysiologic features of allergic upper airway disease improves, as well as the relationship between their development and that of lower airway disease, new strategies of diagnosis and treatment will allow for more effective modulation of the allergic process and associated morbidity.
Christodoulopoulos
P
P
Meakins-Christie Laboratories, McGill University, Montreal, Quebec, Canada.
Cameron
L
L
Durham
S
S
Hamid
Q
Q
D000818:Animals; D002908:Chronic Disease; D006801:Humans; D012221:Rhinitis, Allergic, Perennial / Q000276:immunology / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D006255:Rhinitis, Allergic, Seasonal / Q000276:immunology / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D012852:Sinusitis / Q000276:immunology / Q000378:metabolism / Q000473:pathology* / Q000628:therapy